Condition

Brain Neoplasms

ClinicalTrials.gov condition label

Clinical trials21
Recruiting3
Common interventions25
Lead sponsors shown15

Clinical trials

21 shown
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omicsNCT06001073 · 2022-12-05
RECRUITING
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerNCT05386108 · 2022-08-31
RECRUITING
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid TumorsNCT06128148 · 2022-05-04
RECRUITING
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast AgentNCT06322342 · 2024-08-15
COMPLETED
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsNCT05538130 · 2022-11-30
ACTIVE_NOT_RECRUITING
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.NCT04712721 · 2021-10-14
TERMINATED
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsNCT04644315 · 2021-05-24
TERMINATED
A FIH Study of PF-07284890 in Participants With BRAF V600 Mutant Solid Tumors With and Without Brain InvolvementNCT04543188 · 2021-01-08
TERMINATED
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNCT02900248 · 2017-10-02
TERMINATED
Bevacizumab and Erlotinib in Lung Cancer With Brain Metastases, a Phase II TrialNCT02655536 · 2017-08-01
UNKNOWN
An Evaluation of Non-Invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an Intraparenchymal Pressure Monitoring DeviceNCT02773888 · 2015-12-01
SUSPENDED
Social Cognition in Children Treated for a Brain TumourNCT01599052 · 2011-03-01
COMPLETED
A Study of Bevacizumab in Combination With First- or Second-Line Therapy in Subjects With Treated Brain Metastases Due to Non-Squamous NSCLC (PASSPORT)NCT00312728 · 2006-03-01
COMPLETED
18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in OncologyNCT00207298 · 2005-06-01
COMPLETED
Iressa in the Treatment of Brain Metastases From Non Small Cell Lung CancerNCT00234442 · 2004-07-01
TERMINATED
Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)NCT00076856 · 2004-03-31
COMPLETED
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected CancerNCT00123760 · 2004-02-01
COMPLETED
Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)NCT00034697 · 2001-06-28
TERMINATED
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain MetastasesNCT00121420
TERMINATED
Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)NCT00054795
COMPLETED
Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung CancerNCT00040560
UNKNOWN

Common interventions

Motexafin GadoliniumDRUG2temozolomideDRUG2111In-DACDRUG168Ga-FF58DRUG1AbemaciclibDRUG1AlectinibDRUG1bevacizumabDRUG1Bevacizumab plus erlotinibDRUG1BinimetinibDRUG1DiagnosticPROCEDURE1ElacestrantDRUG1ErlotinibDRUG1First-Line Chemotherapy AgentsDRUG1HS-1000DEVICE1Iressa (Gefitinib)DRUG1JYP0322 100 mg bidDRUG1JYP0322 100 mg qdDRUG1JYP0322 150 mg bidDRUG1JYP0322 150mg tidDRUG1JYP0322 200 mg bidDRUG1JYP0322 200 mg qdDRUG1JYP0322 50 mg qdDRUG1MidazolamDRUG1Observational; No Interventions were given.OTHER1PF-07284890DRUG1

Trial status mix

COMPLETED7
TERMINATED7
RECRUITING3
UNKNOWN2
ACTIVE_NOT_RECRUITING1
SUSPENDED1

Phase mix

PHASE210
PHASE15
PHASE32
EARLY_PHASE11
NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.